
AQT Introductions Overview |
AQT has been used
to screen and assess cognitive dysfunctions such as mild cognitive impairments
of unspecified origins, dementias of the Alzheimer’s type and
dementias with Lewy bodies. Findings suggest that AQT may be used to
identify early cognitive impairments, follow the progression of disease
processes and monitor the effects of medication, among others.
The AQT naming tasks
(a) are objective, based on total naming time as measured with a digital
stopwatch; (b) provide highly reliable results (r = .88 to .96); (c)
are easy and quick to administer and interpret (3-5 minutes per task);
and (d) exhibit no evidence of habituation, learning, or fatigue in
repeated trials over 10 minutes (Wiig et al. 2002). The AQT Color-Form
naming task has been the subject of extensive clinical research, including
functional neuroimaging and determination of clinical utility in differentiating
patients with Alzheimer’s disease from normal controls and patients
with dementia of the Alzheimer’s type and Lewy bodies |
Wiig, E. H., Nielsen, N. P., Minthon, L. & Warkentin, S. (2002). Alzheimer Quick Test: Assessment of Parietal Function. San Antonio, TX: Harcourt Assessment / PsychCorp |
| AQT Topics | Site Map |
Contact Us | Links | Home |
| © 2008 Knowledge Research Institute, Inc. |